The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.
Arthur (Arturo) Durazo is a health psychologist with an emphasis on behavioral medicine, eHealth/mHealth interventions, and health equity. His research focuses on psychosocial factors that promote protective behaviors among those with disproportionate burdens of illness associated with membership in low socioeconomic and ethnic minority groups.
Nadia Gaber, PhD received her PhD from the joint program in medical anthropology from UCSF and UC Berkeley, and is obtaining her MD at UCSF with support from the National Institutes of Health and Medical Scientist Training Program. Her research on the politics of urban health and safety in the U.S.
My research concentrates on oral health research, health disparities research, applied statistical analyses and related methodological issues. Balancing these components is essential to successful and practical oral epidemiology research. Methodological examination helps ground health research and build convincing arguments, while collaborative health research generates opportunities for innovative statistical practice and provides challenges for developing ways to solve real world problems
Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.
Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.
Research focuses on the effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.
Associate Vice Chancellor, Clinical and Translational Science Institute
Otolaryngology
Dr. Jennifer R. Grandis received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr. Grandis was the UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology and Chemical Biology at the University of Pittsburgh.
Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based. Dr. Green has been the PI on research grants and on predoctoral and postdoctoral training grants from NIH,, the VA , CDC, AHRQ, and the Canadian Institute for Health Research.
Valerie Gribben, MD, FAAP is an Assistant Professor of Pediatrics at UCSF. Research interests include: reducing primary and secondhand vaping, cigarette, and marijuana exposure in children and teens; vaping patterns of teenagers during the COVID-19 pandemic; the intersection between digital usage and vaping; social media interventions to assist in vaping cessation; and health disparities in tobacco use and exposure.
Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence. Joseph Guydish, PhD, MPH, is Professor of Medicine and Health Policy at the University of California, San Francisco. His research concerns access, delivery, and organization of substance abuse treatment services.